Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody ...
The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...
In his laboratory at the University of Poitiers in France, Abderrazak El Albani contemplates the rock glittering in his hands. To the untrained eye, the specimen resembles a piece of golden tortellini ...
Complex Launches New Mobile App, Bringing Two Decades of Cultural Influence to the Palm of Your Hand
Key Takeaway: Complex has launched its new iOS mobile app, combining the brand's trusted editorial content with an exclusive shopping experience featuring drops from 100+ streetwear and lifestyle ...
Antibody-drug conjugates (ADCs) have revolutionized the oncology field, offering targeted cancer treatments that improve efficacy without adversely affecting healthy cells. 1 ADCs’ potential extends ...
RESEARCH TRIANGLE PARK, N.C. & KANSAS CITY, Mo.--(BUSINESS WIRE)--ClinTrial Research (CTR), a leading site management organization (SMO), today announced a strategic partnership with Trially®, the ...
A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, recommending it as first-line therapy for folate receptor alpha–high ...
Researchers are exploring the effectiveness of combining antibody drug conjugates and immune checkpoint inhibitors in non-small cell lung cancer. Precision medicine has improved the prognosis for ...
Mike Tresvant, Kirsten Atkinson, and Christopher White, formerly of the SpringHill Company, will lead the Brand Partnerships team. Complex has announced three new executive hires and promotions as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results